Literature DB >> 3793658

Combinations of antiviral agents for treatment of influenza virus infections.

F G Hayden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3793658     DOI： 10.1093/jac/18.supplement_b.177

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Efficient virus extinction by combinations of a mutagen and antiviral inhibitors.

Authors:  N Pariente; S Sierra; P R Lowenstein; E Domingo
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells.

Authors:  Elena A Govorkova; Hong-Bin Fang; Ming Tan; Robert G Webster
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice.

Authors:  Nuha Milad Ashtiwi; Demba Sarr; Tamás Nagy; Z Beau Reneer; Ralph A Tripp; Balázs Rada
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

4.  Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.

Authors:  Jack T Nguyen; Justin D Hoopes; Donald F Smee; Mark N Prichard; Elizabeth M Driebe; David M Engelthaler; Minh H Le; Paul S Keim; R Paul Spence; Gregory T Went
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

5.  Combination chemotherapy for influenza.

Authors:  Elena A Govorkova; Robert G Webster
Journal:  Viruses       Date:  2010-07-27       Impact factor: 5.818

6.  Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.

Authors:  Jack T Nguyen; Donald F Smee; Dale L Barnard; Justin G Julander; Matthew Gross; Menno D de Jong; Gregory T Went
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 7.  Antiviral chemotherapy and prophylaxis of viral respiratory disease.

Authors:  S J Sperber; F G Hayden
Journal:  Clin Lab Med       Date:  1987-12       Impact factor: 1.935

8.  Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.

Authors:  M D de Jong; C A Boucher; D A Cooper; G J Galasso; B Gazzard; J M Lange; J S Montaner; D D Richman; H C Thomas
Journal:  Antiviral Res       Date:  1997-07       Impact factor: 5.970

Review 9.  Antiviral combinations for severe influenza.

Authors:  Jake Dunning; J Kenneth Baillie; Bin Cao; Frederick G Hayden
Journal:  Lancet Infect Dis       Date:  2014-09-08       Impact factor: 25.071

Review 10.  Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES).

Authors:  Erik De Clercq
Journal:  Adv Antivir Drug Des       Date:  2007-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.